nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—Vitamin B12 Metabolism—MTHFR—liver cancer	0.0215	0.0499	CbGpPWpGaD
Gentamicin—Hypocalcaemia—Sorafenib—liver cancer	0.0195	0.0342	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—F2—liver cancer	0.0189	0.0438	CbGpPWpGaD
Gentamicin—Neurotoxicity—Epirubicin—liver cancer	0.017	0.0299	CcSEcCtD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—liver cancer	0.016	0.037	CbGpPWpGaD
Gentamicin—Neurotoxicity—Doxorubicin—liver cancer	0.0157	0.0276	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—SERPINE1—liver cancer	0.0157	0.0364	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ALB—liver cancer	0.0157	0.0364	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.0138	0.0319	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—liver cancer	0.013	0.0302	CbGpPWpGaD
Gentamicin—Venous thrombosis—Epirubicin—liver cancer	0.0122	0.0215	CcSEcCtD
Gentamicin—LRP2—Disease—APCS—liver cancer	0.0121	0.028	CbGpPWpGaD
Gentamicin—Hypokalaemia—Sorafenib—liver cancer	0.0118	0.0207	CcSEcCtD
Gentamicin—Venous thrombosis—Doxorubicin—liver cancer	0.0113	0.0199	CcSEcCtD
Gentamicin—Hypomagnesaemia—Epirubicin—liver cancer	0.0104	0.0182	CcSEcCtD
Gentamicin—Weight decreased—Sorafenib—liver cancer	0.0101	0.0178	CcSEcCtD
Gentamicin—Neuropathy peripheral—Sorafenib—liver cancer	0.00977	0.0172	CcSEcCtD
Gentamicin—Stomatitis—Sorafenib—liver cancer	0.00972	0.0171	CcSEcCtD
Gentamicin—Hypomagnesaemia—Doxorubicin—liver cancer	0.00959	0.0169	CcSEcCtD
Gentamicin—Hepatomegaly—Epirubicin—liver cancer	0.00931	0.0164	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—TNF—liver cancer	0.00926	0.0215	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00888	0.0206	CbGpPWpGaD
Gentamicin—Hepatomegaly—Doxorubicin—liver cancer	0.00861	0.0151	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00856	0.0198	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A2—liver cancer	0.00856	0.0198	CbGpPWpGaD
Gentamicin—Tinnitus—Sorafenib—liver cancer	0.00835	0.0147	CcSEcCtD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC40A1—liver cancer	0.00816	0.0189	CbGpPWpGaD
Gentamicin—Injection site pain—Epirubicin—liver cancer	0.00807	0.0142	CcSEcCtD
Gentamicin—Alopecia—Sorafenib—liver cancer	0.00791	0.0139	CcSEcCtD
Gentamicin—Erythema—Sorafenib—liver cancer	0.00779	0.0137	CcSEcCtD
Gentamicin—Extravasation—Epirubicin—liver cancer	0.00755	0.0133	CcSEcCtD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—liver cancer	0.00748	0.0173	CbGpPWpGaD
Gentamicin—Injection site pain—Doxorubicin—liver cancer	0.00746	0.0131	CcSEcCtD
Gentamicin—Anaemia—Sorafenib—liver cancer	0.0072	0.0127	CcSEcCtD
Gentamicin—Hypocalcaemia—Epirubicin—liver cancer	0.0072	0.0127	CcSEcCtD
Gentamicin—Oliguria—Epirubicin—liver cancer	0.00715	0.0126	CcSEcCtD
Gentamicin—Extravasation—Doxorubicin—liver cancer	0.00699	0.0123	CcSEcCtD
Gentamicin—Leukopenia—Sorafenib—liver cancer	0.00697	0.0123	CcSEcCtD
Gentamicin—Hypertension—Sorafenib—liver cancer	0.00673	0.0118	CcSEcCtD
Gentamicin—Hypocalcaemia—Doxorubicin—liver cancer	0.00666	0.0117	CcSEcCtD
Gentamicin—Arthralgia—Sorafenib—liver cancer	0.00663	0.0117	CcSEcCtD
Gentamicin—Oliguria—Doxorubicin—liver cancer	0.00661	0.0116	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.00655	0.0152	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—UGDH—liver cancer	0.00653	0.0151	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CHN2—liver cancer	0.00642	0.0149	CbGpPWpGaD
Gentamicin—Salivary hypersecretion—Epirubicin—liver cancer	0.0064	0.0113	CcSEcCtD
Gentamicin—Anaphylactic shock—Sorafenib—liver cancer	0.00636	0.0112	CcSEcCtD
Gentamicin—Thrombocytopenia—Sorafenib—liver cancer	0.00623	0.011	CcSEcCtD
Gentamicin—LRP2—Metabolism—EPT1—liver cancer	0.00614	0.0142	CbGpPWpGaD
Gentamicin—Salivary hypersecretion—Doxorubicin—liver cancer	0.00592	0.0104	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IFT88—liver cancer	0.00587	0.0136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—TAT—liver cancer	0.00582	0.0135	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00579	0.0102	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.00572	0.0133	CbGpPWpGaD
Gentamicin—Phlebitis—Epirubicin—liver cancer	0.00555	0.00976	CcSEcCtD
Gentamicin—Decreased appetite—Sorafenib—liver cancer	0.00553	0.00972	CcSEcCtD
Gentamicin—Vascular purpura—Epirubicin—liver cancer	0.00534	0.0094	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—liver cancer	0.00514	0.00903	CcSEcCtD
Gentamicin—Urticaria—Sorafenib—liver cancer	0.00505	0.00889	CcSEcCtD
Gentamicin—Body temperature increased—Sorafenib—liver cancer	0.00503	0.00884	CcSEcCtD
Gentamicin—Purpura—Epirubicin—liver cancer	0.00496	0.00873	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—liver cancer	0.00495	0.0087	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—liver cancer	0.00494	0.00869	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—liver cancer	0.00488	0.00858	CcSEcCtD
Gentamicin—LRP2—Disease—LTF—liver cancer	0.00472	0.0109	CbGpPWpGaD
Gentamicin—Hypersensitivity—Sorafenib—liver cancer	0.00468	0.00824	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—liver cancer	0.00459	0.00807	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00457	0.00804	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—liver cancer	0.00451	0.00794	CcSEcCtD
Gentamicin—Pruritus—Sorafenib—liver cancer	0.0045	0.00791	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—liver cancer	0.00435	0.00765	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.00428	0.00992	CbGpPWpGaD
Gentamicin—Muscular weakness—Epirubicin—liver cancer	0.00422	0.00742	CcSEcCtD
Gentamicin—Dizziness—Sorafenib—liver cancer	0.0042	0.0074	CcSEcCtD
Gentamicin—Eosinophilia—Epirubicin—liver cancer	0.00409	0.0072	CcSEcCtD
Gentamicin—Vomiting—Sorafenib—liver cancer	0.00404	0.00711	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—liver cancer	0.00403	0.00708	CcSEcCtD
Gentamicin—Rash—Sorafenib—liver cancer	0.00401	0.00705	CcSEcCtD
Gentamicin—Dermatitis—Sorafenib—liver cancer	0.00401	0.00705	CcSEcCtD
Gentamicin—Headache—Sorafenib—liver cancer	0.00398	0.00701	CcSEcCtD
Gentamicin—LRP2—Metabolism—GLUL—liver cancer	0.00395	0.00916	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CPT1B—liver cancer	0.00395	0.00916	CbGpPWpGaD
Gentamicin—Muscular weakness—Doxorubicin—liver cancer	0.0039	0.00686	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00389	0.00901	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00386	0.00895	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00386	0.00895	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NR1H4—liver cancer	0.00381	0.00884	CbGpPWpGaD
Gentamicin—Eosinophilia—Doxorubicin—liver cancer	0.00379	0.00666	CcSEcCtD
Gentamicin—Nausea—Sorafenib—liver cancer	0.00378	0.00664	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTA3—liver cancer	0.00375	0.00869	CbGpPWpGaD
Gentamicin—Weight decreased—Epirubicin—liver cancer	0.00374	0.00658	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00371	0.0086	CbGpPWpGaD
Gentamicin—LRP2—Disease—ALDOB—liver cancer	0.00365	0.00846	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Epirubicin—liver cancer	0.00361	0.00635	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SHC3—liver cancer	0.0036	0.00834	CbGpPWpGaD
Gentamicin—Stomatitis—Epirubicin—liver cancer	0.00359	0.00632	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—liver cancer	0.00346	0.00609	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—liver cancer	0.00344	0.00605	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTA4—liver cancer	0.00343	0.00794	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00335	0.00777	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—liver cancer	0.00334	0.00588	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTA2—liver cancer	0.00334	0.00774	CbGpPWpGaD
Gentamicin—Stomatitis—Doxorubicin—liver cancer	0.00332	0.00585	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—liver cancer	0.00329	0.00579	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTA1—liver cancer	0.00322	0.00747	CbGpPWpGaD
Gentamicin—Visual impairment—Epirubicin—liver cancer	0.00319	0.00561	CcSEcCtD
Gentamicin—LRP2—Metabolism—NAT2—liver cancer	0.00319	0.00739	CbGpPWpGaD
Gentamicin—Agranulocytosis—Doxorubicin—liver cancer	0.00318	0.0056	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—liver cancer	0.00308	0.00542	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.00306	0.0071	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALDOB—liver cancer	0.00306	0.00708	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Doxorubicin—liver cancer	0.00305	0.00536	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—liver cancer	0.00295	0.00519	CcSEcCtD
Gentamicin—Alopecia—Epirubicin—liver cancer	0.00292	0.00514	CcSEcCtD
Gentamicin—LRP2—Metabolism—CRABP1—liver cancer	0.00291	0.00676	CbGpPWpGaD
Gentamicin—LRP2—Disease—ADAM17—liver cancer	0.00288	0.00668	CbGpPWpGaD
Gentamicin—Erythema—Epirubicin—liver cancer	0.00288	0.00506	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—liver cancer	0.00285	0.00502	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FST—liver cancer	0.00279	0.00647	CbGpPWpGaD
Gentamicin—LRP2—Disease—PSMA4—liver cancer	0.00271	0.00628	CbGpPWpGaD
Gentamicin—LRP2—Disease—PSMD10—liver cancer	0.00271	0.00628	CbGpPWpGaD
Gentamicin—Alopecia—Doxorubicin—liver cancer	0.0027	0.00476	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TRIO—liver cancer	0.00266	0.00618	CbGpPWpGaD
Gentamicin—Erythema—Doxorubicin—liver cancer	0.00266	0.00469	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—liver cancer	0.00266	0.00468	CcSEcCtD
Gentamicin—LRP2—Disease—GOT2—liver cancer	0.00264	0.00611	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.00262	0.00608	CbGpPWpGaD
Gentamicin—Vertigo—Epirubicin—liver cancer	0.00259	0.00455	CcSEcCtD
Gentamicin—Leukopenia—Epirubicin—liver cancer	0.00258	0.00453	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCR4—liver cancer	0.00255	0.00592	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HPGDS—liver cancer	0.00255	0.0059	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.00253	0.00587	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—liver cancer	0.00249	0.00439	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—liver cancer	0.00249	0.00437	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—liver cancer	0.00246	0.00433	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—liver cancer	0.00245	0.00431	CcSEcCtD
Gentamicin—Vertigo—Doxorubicin—liver cancer	0.00239	0.00421	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—liver cancer	0.00238	0.00419	CcSEcCtD
Gentamicin—Confusional state—Epirubicin—liver cancer	0.00237	0.00417	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—liver cancer	0.00235	0.00413	CcSEcCtD
Gentamicin—Convulsion—Doxorubicin—liver cancer	0.00231	0.00406	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.00231	0.00535	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Epirubicin—liver cancer	0.0023	0.00405	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—liver cancer	0.0023	0.00405	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.00228	0.00528	CbGpPWpGaD
Gentamicin—LRP2—Disease—GOT1—liver cancer	0.00228	0.00528	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PSMD10—liver cancer	0.00227	0.00526	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PSMA4—liver cancer	0.00227	0.00526	CbGpPWpGaD
Gentamicin—Arthralgia—Doxorubicin—liver cancer	0.00227	0.00399	CcSEcCtD
Gentamicin—LRP2—Metabolism—GOT2—liver cancer	0.00221	0.00512	CbGpPWpGaD
Gentamicin—Hypotension—Epirubicin—liver cancer	0.0022	0.00386	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—liver cancer	0.00219	0.00386	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—liver cancer	0.00217	0.00382	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00214	0.00377	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—liver cancer	0.00213	0.00374	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—liver cancer	0.00211	0.00371	CcSEcCtD
Gentamicin—LRP2—Disease—PRKCE—liver cancer	0.0021	0.00487	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP2E1—liver cancer	0.00208	0.00481	CbGpPWpGaD
Gentamicin—Decreased appetite—Epirubicin—liver cancer	0.00204	0.00359	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—liver cancer	0.00203	0.00357	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ADAM17—liver cancer	0.00202	0.00468	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.00201	0.00466	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00198	0.00348	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.00198	0.00458	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—liver cancer	0.00195	0.00343	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYCS—liver cancer	0.00194	0.0045	CbGpPWpGaD
Gentamicin—Feeling abnormal—Epirubicin—liver cancer	0.00194	0.00341	CcSEcCtD
Gentamicin—LRP2—Metabolism—GOT1—liver cancer	0.00191	0.00442	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GGT1—liver cancer	0.00191	0.00442	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PSMA4—liver cancer	0.0019	0.0044	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PSMD10—liver cancer	0.0019	0.0044	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—liver cancer	0.00189	0.00332	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.00189	0.00437	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—liver cancer	0.00187	0.00328	CcSEcCtD
Gentamicin—Body temperature increased—Epirubicin—liver cancer	0.00186	0.00327	CcSEcCtD
Gentamicin—LRP2—Disease—H2AFX—liver cancer	0.00183	0.00424	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP7B—liver cancer	0.00181	0.00419	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ANXA2—liver cancer	0.00181	0.00419	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—liver cancer	0.00179	0.00315	CcSEcCtD
Gentamicin—Hypersensitivity—Epirubicin—liver cancer	0.00173	0.00305	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—liver cancer	0.00173	0.00304	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—liver cancer	0.00172	0.00302	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTP1—liver cancer	0.00171	0.00397	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NR1H4—liver cancer	0.00171	0.00396	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HMOX1—liver cancer	0.00169	0.00392	CbGpPWpGaD
Gentamicin—Pruritus—Epirubicin—liver cancer	0.00166	0.00292	CcSEcCtD
Gentamicin—LRP2—Disease—MTHFR—liver cancer	0.00166	0.00385	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—liver cancer	0.00166	0.00384	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—liver cancer	0.0016	0.00282	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTM1—liver cancer	0.00157	0.00365	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—liver cancer	0.00155	0.00273	CcSEcCtD
Gentamicin—Pruritus—Doxorubicin—liver cancer	0.00154	0.00271	CcSEcCtD
Gentamicin—Vomiting—Epirubicin—liver cancer	0.00149	0.00263	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP1A1—liver cancer	0.00149	0.00346	CbGpPWpGaD
Gentamicin—Rash—Epirubicin—liver cancer	0.00148	0.00261	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—liver cancer	0.00148	0.0026	CcSEcCtD
Gentamicin—Headache—Epirubicin—liver cancer	0.00147	0.00259	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRKCE—liver cancer	0.00147	0.00341	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—liver cancer	0.00144	0.00253	CcSEcCtD
Gentamicin—Nausea—Epirubicin—liver cancer	0.0014	0.00246	CcSEcCtD
Gentamicin—LRP2—Disease—APC—liver cancer	0.0014	0.00323	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF2—liver cancer	0.00139	0.00323	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTHFR—liver cancer	0.00139	0.00322	CbGpPWpGaD
Gentamicin—Vomiting—Doxorubicin—liver cancer	0.00138	0.00243	CcSEcCtD
Gentamicin—Rash—Doxorubicin—liver cancer	0.00137	0.00241	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—liver cancer	0.00137	0.00241	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPARA—liver cancer	0.00136	0.00316	CbGpPWpGaD
Gentamicin—Headache—Doxorubicin—liver cancer	0.00136	0.0024	CcSEcCtD
Gentamicin—LRP2—Disease—BRAF—liver cancer	0.00131	0.00304	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CSF2—liver cancer	0.0013	0.00302	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—liver cancer	0.00129	0.00227	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—H2AFX—liver cancer	0.00128	0.00297	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CD—liver cancer	0.00123	0.00284	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	0.00123	0.00284	CbGpPWpGaD
Gentamicin—LRP2—Disease—SERPINE1—liver cancer	0.00121	0.00281	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—liver cancer	0.00117	0.00271	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—liver cancer	0.00116	0.00269	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARG—liver cancer	0.00113	0.00261	CbGpPWpGaD
Gentamicin—LRP2—Disease—RAF1—liver cancer	0.0011	0.00254	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CB—liver cancer	0.00107	0.00248	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTOR—liver cancer	0.00107	0.00248	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KDR—liver cancer	0.00106	0.00246	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK14—liver cancer	0.00105	0.00244	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ESR1—liver cancer	0.00103	0.0024	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CD—liver cancer	0.00103	0.00238	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—F2—liver cancer	0.00102	0.00237	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALB—liver cancer	0.00101	0.00235	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1B—liver cancer	0.001	0.00233	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—liver cancer	0.000977	0.00226	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—liver cancer	0.000977	0.00226	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—liver cancer	0.000948	0.0022	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—liver cancer	0.000926	0.00215	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BRAF—liver cancer	0.000919	0.00213	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CB—liver cancer	0.000896	0.00208	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—liver cancer	0.000895	0.00207	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CYCS—liver cancer	0.000871	0.00202	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—liver cancer	0.000859	0.00199	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SERPINE1—liver cancer	0.00085	0.00197	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—liver cancer	0.000826	0.00192	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—liver cancer	0.000768	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAF1—liver cancer	0.000767	0.00178	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—liver cancer	0.000766	0.00178	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000757	0.00176	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—liver cancer	0.000749	0.00174	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MTOR—liver cancer	0.000749	0.00174	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—liver cancer	0.00071	0.00164	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—liver cancer	0.000703	0.00163	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—liver cancer	0.000689	0.0016	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—liver cancer	0.000688	0.00159	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—liver cancer	0.00067	0.00155	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JUN—liver cancer	0.000669	0.00155	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—liver cancer	0.000664	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—liver cancer	0.000652	0.00151	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—liver cancer	0.000651	0.00151	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—liver cancer	0.000649	0.0015	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK8—liver cancer	0.000633	0.00147	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PPARA—liver cancer	0.000612	0.00142	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—liver cancer	0.000603	0.0014	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—liver cancer	0.000584	0.00135	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—liver cancer	0.000579	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—liver cancer	0.000577	0.00134	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—liver cancer	0.000546	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—liver cancer	0.000538	0.00125	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—liver cancer	0.000536	0.00124	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—liver cancer	0.000533	0.00123	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—liver cancer	0.000497	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—liver cancer	0.000457	0.00106	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—liver cancer	0.000455	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—liver cancer	0.000446	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—liver cancer	0.000442	0.00102	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—liver cancer	0.000422	0.000979	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—RAF1—liver cancer	0.000411	0.000953	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—liver cancer	0.000404	0.000937	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—liver cancer	0.000373	0.000864	CbGpPWpGaD
